HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 07, July 2017 – Food Science & Technology       » Scientists Demonstrate RNAi as an Antiviral Immunity in Mammals       » Singaporeans' Pain Costs Economy USD 6.2 billion Each Year       » China Fights Academic Paper Fraud After Peer Review Scandal       » Human Heart Tissue Grown from Stem Cells Improves Drug Testing       » Bioengineered Human Livers Mimic Natural Development       » Does Consuming Low-Fat Dairy Increase the Risk of Parkinson's Disease?      
BIOBOARD - AUSTRALIA
Primary Health Care signs Australia distribution agreement for iGeneScreen TM prenatal test
INEX Innovations Exchange Pte. Ltd., a leading women's and fetal health diagnostics company announced that Australian listed healthcare company, Primary Health Care Ltd, has signed an exclusive distribution agreement for iGeneScreenTM Prenatal Test in Australia. The agreement covers all the territories and major cities in Australia, including Sydney, Perth, Melbourne, Brisbane and Adelaide.

iGeneScreenTM is a non-invasive prenatal blood test that detects Trisomy 21 (Down Syndrome) and Trisomy 18 (Edwards Syndrome) with 99 % accuracy. It is a non-invasive screening test requiring only a 10ml blood sample from pregnant women at 12 weeks gestation onwards.

This represents a major step forward over the current invasive amniocentesis or chorionic villus sampling that most “at risk” pregnant mothers are offered to take. Current routine prenatal testing methods such as the Nuchal Translucency Scan and Triple Test have high false positive and false negative rates. 

Primary Health Care through its network of practices is one of Australia's largest pathology providers with approximately 100 pathology laboratories, and 1500 collection centres around the country. The agreement will allow patients to access this testing service through Primary's laboratories.

“This agreement signals our progress in facilitating the adoption of an important test in the Australian market. We are delighted that pregnant mothers can now have access to a non-invasive prenatal test, and that they no longer have to endure the stresses associated with existing prenatal tests,” said Sidney Yee, Ph.D., Executive Director of INEX. “We look forward to working closely with Primary Health Care in launching the test across major cities in Australia in the coming months.”

Announcing the agreement, Dr. Narelle Hadlow, a pathologist at Primary Health Care Ltd's Western Australian pathology practice said, “This announcement is another significant step forward in our practice's aim to provide better health care insights to doctors so as to improve the care of their patients. The reach that our laboratory network can provide patients will ensure that this innovative technology will be available to pregnant mothers nationwide.”

Click here for the complete issue.

NEWS CRUNCH  
news Nestlé Introduces their Singapore R&D Centre
news Vitafoods Asia Elevates 2017 Learning Programme
news The Seventh International Meeting on Synthetic Biology (SB 7.0)
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy